Company

MSD Plans to Introduce Over 50 New Drugs and Vaccines to China in the Next Five Years

CompanyDeals

Novo Nordisk and Broad Institute Collaborate on Diabetes and Cardiometabolic Research

CompanyDrug

Janssen’s Rybrevant Combo Meets Primary Endpoint in Advanced NSCLC Study

CompanyPolicy / Regulatory

FDA Addresses Looming Migraine Treatment Shortage with Tonix Pharmaceuticals Commitment

CompanyDrug

Henan Zhongshuai’s Dexmethylphenidate Hydrochloride Capsules Target Priority Review for Pediatric ADHD

CompanyDrug

Amneal Pharmaceuticals Receives China Approval for Sevelamer Carbonate

CompanyDrug

CSPC Pharmaceutical’s Narlumosbart Approved by NMPA for Bone Giant Cell Tumors

CompanyDrug

Jiangsu Hengrui’s HER2-Targeted ADC SHR-A1811 Aims for CDE’s BTD Status

Policy / Regulatory

NMPA Drafts Guidelines for Supervising Online Drug Exchange Platforms

CompanyDrug

Genentech Files for FDA Approval of Crovalimab for PNH, Challenging Soliris

CompanyDeals

uBriGene and YolTech Therapeutics Join Forces to Advance mRNA Therapy and Gene Therapy

Policy / Regulatory

CDE’s 2022 Drug Review Report: A Year of Pandemic Response and Regulatory Milestones